PDCD1 and head and neck squamous cell carcinoma: In addition to these traditional treatments, immune checkpoint blockades such as anti-programmed cell death 1 (anti-PD-1) and anti-programmed cell death 1 ligand 1 (anti-PD-L1) antibodies have displayed great efficacy in the treatment of HNSCC (3, 4).